MB
KDNY

MPM BioImpact’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

MPM BioImpact’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,003,406
Closed -$38.6M – 36
2023
Q2 		$38.6M Buy
1,003,406
+805,600
+407% +$31M 7.76% 3
2023
Q1 		$4.58M Buy
197,806
+117,806
+147% +$2.73M 1.19% 22
2022
Q4 		$2.1M Buy
+80,000
New +$2.1M 0.54% 28